Wolfe Repass (FLD) details planned stock sale and past share disposals

Rhea-AI Filing Summary

Wolfe Repass submitted a notice related to potential sales of common stock of FLD. The filing lists a proposed transaction involving 1,180 common shares, connected with restricted stock vesting dated July 31, 2026, and a proposed sale date of August 3, 2026 on NASDAQ. It also details several prior sales of common stock by Wolfe Repass over the preceding three months, including multiple transactions in May, June, and July 2026 with specified share amounts and total consideration.

Key Figures

Proposed shares to be sold: 1,180 shares Shares sold on 05/04/2026: 1,947 shares Consideration on 05/04/2026: 2,768.64 +5 more

8 metrics

Proposed shares to be sold 1,180 shares Common stock referenced in planned transaction connected to restricted stock vesting

Shares sold on 05/04/2026 1,947 shares Common stock listed under Securities Sold During The Past 3 Months

Consideration on 05/04/2026 2,768.64 Total consideration for 1,947 common shares sold on 05/04/2026

Shares sold on 05/20/2026 3,126 shares Common stock sale disclosed for 05/20/2026

Consideration on 05/20/2026 3,779.96 Total consideration for 3,126 common shares on 05/20/2026

Shares sold on 06/02/2026 1,310 shares Common stock sale disclosed for 06/02/2026

Shares sold on 07/02/2026 1,131 shares Common stock sale disclosed for 07/02/2026

Consideration on 07/02/2026 556.79 Total consideration for 1,131 common shares on 07/02/2026

Key Terms

Form 144, Restricted Stock Vesting, Securities Sold During The Past 3 Months

3 terms

Form 144 regulatory

"144: Securities Sold During The Past 3 Months"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Vesting financial

"Common | 07/31/2026 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Securities Sold During The Past 3 Months regulatory

"144: Securities Sold During The Past 3 Months"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/03/2026 - 04:09 PM Accepted by SEC EDGAR 08/03/2026 - 04:08 PM Learn about SEC filing dates

FAQ

What does the Form 144 filing for FLD indicate?

The Form 144 filing indicates Wolfe Repass plans a potential sale of 1,180 common shares of FLD, linked to restricted stock vesting on July 31, 2026, with a proposed sale date of August 3, 2026 on NASDAQ.

How many FLD shares are proposed to be sold under this Form 144?

The notice references a potential sale of 1,180 common shares of FLD. This amount is associated with restricted stock vesting and is tied to a proposed transaction scheduled for August 3, 2026 on NASDAQ.

What prior FLD stock sales by Wolfe Repass are disclosed in this Form 144?

The filing lists prior sales of FLD common stock by Wolfe Repass over three months: 1,947 shares on May 4, 2026, 3,126 shares on May 20, 2026, 1,310 shares on June 2, 2026, and 1,131 shares on July 2, 2026.

What total consideration amounts are shown for recent Wolfe Repass FLD sales?

The disclosure shows total consideration of 2,768.64 for 1,947 shares on May 4, 2026, 3,779.96 for 3,126 shares on May 20, 1,185.81 for 1,310 shares on June 2, and 556.79 for 1,131 shares on July 2, 2026.

How is restricted stock vesting connected to the FLD Form 144 filing?

The filing links the proposed sale of 1,180 common shares of FLD to a Restricted Stock Vesting event dated July 31, 2026. These vested shares form the basis for the planned transaction referenced for August 3, 2026.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1180	554.13	50783350	08/03/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/31/2026	Restricted Stock Vesting	Issuer			1180	07/31/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Wolfe Repass 2942 North 24th Street Suite 115, #42035 Phoenix AZ 85016	Common	05/04/2026	1947	2768.64
Wolfe Repass 2942 North 24th Street Suite 115, #42035 Phoenix AZ 85016	Common	05/20/2026	3126	3779.96
Wolfe Repass 2942 North 24th Street, Suite 115 #42035 Phoenix AZ 85016	Common	06/02/2026	1310	1185.81
Wolfe Repass 2942 North 24th Street, Suite 115 #42035 Phoenix AZ 85016	Common	07/02/2026	1131	556.79

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)